Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Dentaltek Research AG

History from 28 Oct 2022

UID
CHE-313.827.051
Legal form
AG
Canton
ZH
Founded
28 Oct 2022
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 152k
38k76k114k152k5 Jul 2023 · CHF 100k10 Jul 2025 · CHF 130k14 Aug 2026 · CHF 152k202420252026
  • shares

Record

  1. Company formed

    Founded 28 Oct 2022

    SHAB HR01-1005595305 ↗
  2. Converted to an AG

    GmbH → AG

    SHAB HR02-1005786547 ↗
  3. Capital set in the conversion to an AG

    Not assessed

    Paid in cash

    Nominal capital
    20’000 → 100’000
    Shares
    — → 100’000
    New shares, % of post-step shares
    — (conversion to an AG)

    Umwandlung: Die Gesellschaft mit beschränkter Haftung hat das Stammkapital auf CHF 100'000.00 erhöht und wird gemäss Umwandlungsplan vom 28.06.2023 und Bilanz per 31.12.2022 mit Aktiven von CHF 18'970.80 und Passiven (Fremdkapital) von CHF 0.00 in eine Aktiengesellschaft umgewandelt. Die Unterbilanz wird anlässlich der Kapitalerhöhung beseitigt. Rechtsform neu: Aktiengesellschaft. Aktienkapital neu: CHF 100'000.00 [bisher: CHF 20'000.00]. Liberierung Aktienkapital neu: CHF 100'000.00. Aktien neu: 100'000 Namenaktien zu CHF 1.00. Vinkulierung neu: Die Übertragbarkeit der Namenaktien ist nach Massgabe der Statuten beschränkt.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005786547 ↗
  4. Name changed

    Dentaltek Research GmbH → Dentaltek Research AG

    SHAB HR02-1005786547 ↗
  5. Capital band adopted

    SHAB HR02-1006361452 ↗
  6. Capital increase

    Not assessed

    Issued from conditional capital

    Nominal capital
    100’000 → 129’522
    Shares
    100’000 → 129’522
    New shares, % of post-step shares
    22.8% (29’522 new)

    Aktienkapital neu: CHF 129'522.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 129'522.00 [bisher: CHF 100'000.00]. Aktien neu: 129'522 Namenaktien zu CHF 1.00 [bisher: 100'000 Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006380307 ↗
  7. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    129’522 → 152’377
    Shares
    129’522 → 152’377
    New shares, % of post-step shares
    15.0% (22’855 new)

    Aktienkapital neu: CHF 152'377.00 [bisher: CHF 129'522.00]. Liberierung Aktienkapital neu: CHF 152'377.00 [bisher: CHF 129'522.00]. Aktien neu: 152'377 Namenaktien zu CHF 1.00 [bisher: 129'522 Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.72 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006731057 ↗

Published by 16 Aug 2026

Latest available record · 8 Oct 2026